Quest Laboratories IPO is to open on May 15. Quest Laboratories is a Mainline IPO to raise ₹43.16 crores via IPO. The Quest Laboratories IPO price band is fixed at ₹93 to ₹97 with a market lot of 1200 Shares. Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
What is Quest Laboratories IPO GMP Today?
The Quest Laboratories IPO GMP aka Grey Market Premium is ₹70.
What is Quest Laboratories IPO Kostak Rates Today?
The Quest Laboratories IPO Kostak Rate is ₹-.
What is Quest Laboratories IPO Subject to Sauda Price Today?
The Quest Laboratories IPO subject to sauda rates is ₹70,000.
Quest Laboratories IPO Expected Returns?
The Quest Laboratories expected return is 72%.
Quest Laboratories IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | Kostak | Subject to |
| Today | ₹70 | ₹- | ₹70000 |
| 22 May | ₹70 | ₹- | ₹70000 |
| 21 May | ₹50 | ₹- | ₹45000 |
| 20 May | ₹50 | ₹- | ₹45000 |
| 17 May | ₹20 | ₹- | ₹18,000 |
| 16 May | ₹- | ₹- | ₹- |
| 15 May | ₹- | ₹- | ₹- |
| 14 May | ₹- | ₹- | ₹- |
| 13 May | ₹- | ₹- | ₹- |
| 10 May | ₹- | ₹- | ₹- |
| 9 May | ₹- | ₹- | ₹- |
Quest Laboratories IPO GMP aka Grey Market Premium FAQs:
What is Quest Laboratories IPO GMP Today?
What is Quest Laboratories IPO Kostak Rate Today?
What is Quest Laboratories IPO Subject to Sauda Today?
What is Quest Laboratories IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Quest Laboratories IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.